Preventive Nutrition and Food Science

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Prevention of Alloxan-induced Diabetes by Se-Methylselenocysteine Pretreatment in Rats: The Effect on Antioxidant System in Pancreas

  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

In this study, we assessed the effects of Se-methylselenocysteine (MSC) pretreatment on the antioxidant system in the pancreas and the development of alloxan-induced diabetes in rats. The rats were treated with MSC at a dose of 0.75 mg/rat/day for 2 weeks. The MSC-treated rats evidenced significantly increased glutathione content, GSH/GSSG ratio, and glutathione peroxidase (GPx) and glutathione reductase (GRd) activities in the pancreas. Diabetes was induced via alloxan injection. The alloxan-diabetic rats evidenced significantly reduced glutathione content and glucose 6-phosphate dehydrogenase (G6PD) activity and increased catalase activity in the pancreas, when measured 3 days after the alloxan injection. 2-week MSC pretreatment was shown to prevent the alloxan-induced hyperglycemia as well as changes in glutathione content, G6PD activity, and catalase activity. The results of this study indicate that the prevention of alloxan-diabetes by MSC pretreatment is associated with its effects on antioxidants in the pancreas, namely, the increase in cellular content and the reduction of glutathione by the facilitation of glutathione recycling induced via increased GPx, GRd, and G6PD activities.

Keywords

References

  1. Papp LV, Lu J, Holmgren A, Khanna KK. 2007. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 9: 775-806 https://doi.org/10.1089/ars.2007.1528
  2. Rayman MP. 2000. The importance of selenium to human health. Lancet 356: 233-241 https://doi.org/10.1016/S0140-6736(00)02490-9
  3. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR. 1996. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276: 1957-1963 https://doi.org/10.1001/jama.1996.03540240035027
  4. Ceriello A, Motz E. 2004. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24: 816-823 https://doi.org/10.1161/01.ATV.0000122852.22604.78
  5. Evans JL, Maddux BA, Goldfine ID. 2005. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 7: 1040-1052 https://doi.org/10.1089/ars.2005.7.1040
  6. Fridlyand LE, Philipson LH. 2005. Oxidative reactive species in cell injury: Mechanisms in diabetes mellitus and therapeutic approaches. Ann N Y Acad Sci 1066: 136-151 https://doi.org/10.1196/annals.1363.019
  7. Houstis N, Rosen ED, Lander ES. 2006. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440: 944-948 https://doi.org/10.1038/nature04634
  8. Mueller AS, Pallauf J. 2006. Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice. J Nutr Biochem 17: 548-560 https://doi.org/10.1016/j.jnutbio.2005.10.006
  9. Stapleton SR. 2000. Selenium: an insulin-mimetic. Cell Mol Life Sci 57: 1874-1879 https://doi.org/10.1007/PL00000669
  10. Erbayraktar Z, Yilmaz O, Artmann AT, Cehreli R, Coker C. 2007. Effects of selenium supplementation on antioxidant defense and glucose homeostasis in experimental diabetes mellitus. Biol Trace Elem Res 118: 217-226 https://doi.org/10.1007/s12011-007-0037-5
  11. Faure P, Ramon O, Favier A, Halimi S. 2004. Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients. Eur J Clin Invest 34: 475-481 https://doi.org/10.1111/j.1365-2362.2004.01362.x
  12. Bleys J, Navas-Acien A, Guallar E. 2007. Serum selenium and diabetes in U.S. adults. Diabetes Care 30: 829-834 https://doi.org/10.2337/dc06-1726
  13. Abdulah R, Miyazaki K, Nakazawa M, Koyama H. 2005. Chemical forms of selenium for cancer prevention. J Trace Elem Med Biol 19: 141-150 https://doi.org/10.1016/j.jtemb.2005.09.003
  14. Letavayova L, Vlckova V, Brozmanova J. 2006. Selenium: from cancer prevention to DNA damage. Toxicology 227: 1-14 https://doi.org/10.1016/j.tox.2006.07.017
  15. Suzuki KT, Tsuji Y, Ohta Y, Suzuki N. 2008. Preferential organ distribution of methylselenol source Se-methylselenocysteine relative to methylseleninic acid. Toxicol Appl Pharmacol 227: 76-83 https://doi.org/10.1016/j.taap.2007.10.001
  16. Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358 https://doi.org/10.1016/0003-2697(79)90738-3
  17. Reed DJ, Babson JR, Beatty PW, Brodie AE, Ellis WW, Potter DW. 1980. High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. Anal Biochem 106: 55-62 https://doi.org/10.1016/0003-2697(80)90118-9
  18. Seelig GF, Meister A. 1984. Gamma-glutamylcysteine synthetase from erythrocytes. Anal Biochem 141: 510-514 https://doi.org/10.1016/0003-2697(84)90079-4
  19. Paglia DE, Valentine WN. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158-169
  20. Cohen MB, Duvel DL. 1988. Characterization of the inhibition of glutathione reductase and the recovery of enzyme activity in exponentially growing murine leukemia (L1210) cells treated with 1,3-bis(2-chloroethyl)-1- nitrosourea. Biochem Pharmacol 37: 3317-3320 https://doi.org/10.1016/0006-2952(88)90645-4
  21. Bautista JM, Mason PJ, Luzzatto L. 1992. Purification and properties of human glucose-6-phosphate dehydrogenase made in E. coli. Biochim Biophys Acta 1119: 74-80 https://doi.org/10.1016/0167-4838(92)90237-8
  22. Misra HP, Fridovich I. 1972. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247: 3170-3175
  23. Aebi H. 1984. Catalase in vitro. Methods Enzymol 105: 121-126 https://doi.org/10.1016/S0076-6879(84)05016-3
  24. Mandrup-Poulsen T, Helqvist S, Wogensen LD, Molvig J, Pociot F, Johannesen J, Nerup J. 1990. Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells. Curr Top Microbiol Immunol 164: 169-193
  25. Fridlyand LE, Philipson LH. 2004. Does the glucose-dependent insulin secretion mechanism itself cause oxidative stress in pancreatic beta-cells? Diabetes 53: 1942-1948 https://doi.org/10.2337/diabetes.53.8.1942
  26. Malaisse WJ. 1982. Alloxan toxicity to the pancreatic B-cell. A new hypothesis. Biochem Pharmacol 31: 3527-3534 https://doi.org/10.1016/0006-2952(82)90571-8
  27. Jorns A, Tiedge M, Lenzen S, Munday R. 1999. Effect of superoxide dismutase, catalase, chelating agents, and free radical scavengers on the toxicity of alloxan to isolated pancreatic islets in vitro. Free Radic Biol Med 26: 1300-1304 https://doi.org/10.1016/S0891-5849(98)00325-6
  28. Mueller AS, Pallauf J, Rafael J. 2003. The chemical form of selenium affects insulinomimetic properties of the trace element: investigations in type II diabetic dbdb mice. J Nutr Biochem 14: 637-647 https://doi.org/10.1016/j.jnutbio.2003.08.001
  29. Azrak RG, Cao S, Pendyala L, Durrani FA, Fakih M, Combs GF Jr, Prey J, Smith PF, Rustum YM. 2007. Efficacy of increasing the therapeutic index of irinotecan, plasma and tissue selenium concentrations is methylselenocysteine dose dependent. Biochem Pharmacol 73: 1280-1287 https://doi.org/10.1016/j.bcp.2006.12.020.
  30. Xu Y, Osborne BW, Stanton RC. 2005. Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am J Physiol Renal Physiol 289: F1040-F1047 https://doi.org/10.1152/ajprenal.00076.2005
  31. Yokota S, Asayama K. 1992. Proliferation of myocardial peroxisomes in experimental rat diabetes: a biochemical and immunocytochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol 63: 43-49 https://doi.org/10.1007/BF02899243
  32. Tapiero H, Townsend DM, Tew KD. 2003. The antioxidant role of selenium and seleno-compounds. Biomed Pharmacother 57: 134-144 https://doi.org/10.1016/S0753-3322(03)00035-0
  33. Jung U, Zheng X, Yoon SO, Chung AS. 2001. Se-methylselenocysteine induces apoptosis mediated by reactive oxygen species in HL-60 cells. Free Radic Biol Med 31: 479-489 https://doi.org/10.1016/S0891-5849(01)00604-9
  34. Drake EN. 2006. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant. Med Hypotheses 67: 318-322 https://doi.org/10.1016/j.mehy.2006.01.058
  35. Yan L, Spallholz JE. 1993. Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells. Biochem Pharmacol 45: 429-437 https://doi.org/10.1016/0006-2952(93)90080-G

Cited by

  1. Effect of Se-methylselenocysteine on the Antioxidant System in Rat Tissues vol.15, pp.4, 2010, https://doi.org/10.3746/jfn.2010.15.4.267